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Many bacterial pathogens interfere with the contact system (kallikrein–kinin system) in human
plasma. Activation of this system has two consequences: cleavage of high-molecular-mass
kininogen (HK) resulting in release of the potent proinflammatory peptide bradykinin, and initiation
of the intrinsic pathway of coagulation. In this study, two species of the Gram-negative anaerobic
commensal organism Bacteroides, namely Bacteroides fragilis and Bacteroides thetaiotaomicron,
were found to bind HK and fibrinogen, the major clotting protein, from human plasma as shown by
immunoelectron microscopy and Western blot analysis. In addition, these Bacteroides species
were capable of activating the contact system at its surface leading to a significant prolongation of
the intrinsic coagulation time and also to the release of bradykinin. Members of the genus
Bacteroides have been known to act as opportunistic pathogens outside the gut, with B. fragilis
being the most common isolate from clinical infections, such as intra-abdominal abscesses and
bacteraemia. The present results thus provide more insight into how Bacteroides species cause
infection.
INTRODUCTION
Bacteroides are obligately anaerobic, Gram-negative, pleo-
morphic rods that have a role in the human context as a
member of the normal gut microbiota. Bacteroides fragilis
is the type species of the genus. It is the most frequent
species isolated from clinical infections and is considered to
be the most virulent species, even though it is present in
the gut at levels 100- to 1000-fold lower than other
intestinal Bacteroides species. Bacteroides thetaiotaomicron
is a prominent member of the distal intestinal microflora,
comprising 6% of all bacteria and 12% of all Bacteroides in
the human intestine. Apart from being a commensal
bacteria in the gut, Bacteroides can also be opportunistic
pathogens, mostly causing post-operative infections of the
peritoneal cavity and bacteraemia (Wexler, 2007).
Anaerobic infections involve many different bacteria, but
B. fragilis is isolated from most infections. The mortality
rate of infections caused by B. fragilis, which are treated
appropriately, is 19%. However, if the infection is left
untreated, the mortality rate climbs to 60% (Goldstein,
1996). Bacteroides are reported to have the most effective
antibiotic resistance mechanisms of any anaerobic patho-
gen (So ´ki et al., 2006), with most members of the species
being resistant to b-lactam agents (Nord & Olsson-
Liljequist, 1981) and tetracycline (Kislak, 1972).
During establishment of a systemic infection such as
bacteraemia, the invading organism has to contend with
the full gambit of the host immune response. A component
of this response, and one that is increasingly being
recognized as an important aspect of the host immune
defence, is contact activation of the intrinsic coagulation
pathway. Activation of the contact system (kallikrein–kinin
system) results in the initiation of procoagulative and
proinflammatory cascades (Risberg et al., 1991). This
system encompasses three serine proteinases, factor XI
(FXI), factor XII (FXII) and plasma prekallikrein (PK), and
a non-enzymic co-factor, high-molecular-mass kininogen
(HK). HK circulates in human plasma forming equimolar
complexes with FXI and PK (Mu ¨ller-Esterl, 1989). The
system becomes activated upon exposure of FXII and HK
to negatively charged surfaces. This causes the auto-
activation of FXII to FXIIa and of PK to kallikrein. As a
result, HK is cleaved by kallikrein releasing the nonapep-
tide bradykinin (Kaplan & Silverberg, 1987). FXI also
becomes activated resulting in initiation of the intrinsic
pathway of coagulation. Bradykinin is a proinflammatory
peptide causing fever and pain, smooth-muscle contraction
Abbreviations: aPPT, activated partial thromboplastin time; BF-FBP,
fibrinogen binding protein in B. fragilis; CMK, chloromethylketone; CNBr,
cyanogen bromide; FXI, factor XI; FXII, factor XII; HK, high-molecular-
mass kininogen; PK, prekallikrein; PT, prothrombin time; TCT, thrombin
time.
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production of prostaglandins and nitric oxide (Hall,
1992). Many bacterial pathogens, such as Streptococcus
pyogenes, Staphylococcus aureus and Salmonella, can bind
and assemble the components of the contact system leading
to activation and bradykinin release (Frick et al., 2007;
Herwald et al., 2003). In addition, recent work has shown
that further processing of HK at the surface of bacterial
pathogens generates antibacterial fragments from domain
D3 of HK, including the 26 aa peptide NAT26 (Frick et al.,
2006). Thus, the contact system can be regarded as an
important branch of innate immunity. Release of kinins at
the site of bacterial infection has a dual role. On one hand,
it is beneficial to the host as kinins aid in host defence to
pathogens. They help in recruitment of defence cells such
as neutrophils (Stuardo et al., 2004) and monocytes
(Barbasz et al., 2008). On the other hand, release of
bradykinin increases vascular permeability, which helps
pathogens to colonize other tissues as well as allowing them
access to more nutrients, due to increased infiltration of
plasma into the site of infection (Karkowska-Kuleta et al.,
2009). Hence, contact system activation at the surface of
bacterial cells can be seen as an important pathogenicity
factor.
Despite the fact that Bacteroides are commonly isolated
from clinical specimens, the pathogenic mechanisms of this
bacterium are not well elucidated. Various virulence factors
have been described, such as extracellular enzymes capable
of degrading host molecules (Patrick, 2002) and binding to
extracellular components such as fibronectin, collagen and
vitronectin (Szo ¨ke et al., 1996). The capsular polysaccha-
ride complex was also thought to be a virulence factor
(Krinos et al., 2001). However, Bacteroidetes are commonly
associated with opportunistic infection and also contain
diverse polysaccharide loci, suggesting that the capsular
polysaccharide may play more of a role in the prevention of
bacteriophage infection in the gastrointestinal tract
(Patrick et al., 2010). A fibrinogen-binding protein, BF-
FBP, was identified in B. fragilis and it was also shown that
the bacterium possesses fibrinolytic activity (Houston et al.,
2010) and has an outer-membrane protein that interacts
with components of the fibrinolytic system (Ferreira et al.,
2009). Recently, homologues of the streptococcal cysteine
protease, SpeB, were identified in B. fragilis (Thornton
et al., 2010).
Given the ability of members of the genus Bacteroides to
cause anaerobic infections, and the paucity of information
on virulence mechanisms for these bacteria, we investigated
whether the bacteria are capable of activation of the contact
system. The results suggest that the ability of Bacteroides to
cause infection may be aided by their ability to bind
kininogen and fibrinogen from human plasma. The results
also showed that the contact system could be activated on
the surface of both B. fragilis and B. thetaiotaomicron. This
resulted in a prolongation of the time taken to activate the
intrinsic pathway of coagulation and a release of brady-
kinin from HK. During infection, all of these processes
would allow the bacteria more access to nutrients due to
serum seepage through an increase in vascular permeab-
ility. It would also give the bacteria greater ability to move
outwards from the site of infection due to the binding of
fibrinogen and contact factors, leading to a delay in
coagulation.
METHODS
Bacteria, growth conditions and plasma sources. The B. fragilis
strain 638R was a kind gift from Dr Sheila Patrick, Queen’s
University, Belfast, Northern Ireland. The B. thetaiotaomicron strain
VPI-5482 was purchased from the American Type Culture Collection.
Bacteria were grown anaerobically overnight to stationary phase in
BHI broth (Difco) supplemented with 5 mg haemin ml
21 (Sigma),
0.5 mg menadione ml
21 (Fluka) and 50 mg L-cysteine ml
21 (Sigma) at
37 uC for 18 h. Fresh frozen citrated plasma from healthy individuals
was obtained from the blood bank at Lund University Hospital, Lund,
Sweden, and kept frozen at 280 uC until use. Human kininogen-
depleted plasma, human FXI-depleted plasma, human FXII-depleted
plasma and human PK-depleted plasma were purchased from George
King Bio-Medical.
Proteins, antibodies and reagents. Human HK was purchased
from Kordia and human fibrinogen was from Sigma. Anti-NAT26
antibodies were raised in rabbits as described previously (Frick et al.,
2006), rabbit anti-human fibrinogen was purchased from
DakoCytomation, sheep anti-FXII from the Binding Site and goat
anti-FXI from Affinity Biologicals. Sheep anti-human HK (AS88) and
rabbit anti-PK were a kind gift from Heiko Herwald, Lund University,
Sweden. Horseradish peroxidase (HRP)-conjugated goat anti-rabbit
IgG was purchased from Pierce, HRP-conjugated donkey anti-sheep
IgG from MP Biomedicals and HRP-conjugated Protein A from
Sigma. The FXII/plasma kallikrein inhibitor H-D-Pro-Phe-Arg-
chloromethylketone (CMK) peptide was purchased from Bachem
Feinchemikalien.
Plasma absorption assay. An overnight culture of bacteria grown
to stationary phase was washed twice and resuspended in PBS
(116 mM NaCl, 1.7 mM KH2PO4, 4.9 mM Na2HPO4.2H 2O). One
millilitre of a 2610
9 bacteria ml
21 suspension was incubated with
1 ml citrated human plasma for 1 h at 37 uC. As a control, bacteria
were also incubated with PBS. The bacterial cells were recovered and
washed with PBS four times to remove any unbound plasma proteins.
Bound proteins (proteins bound to the surface of the bacteria and not
removed by washing) were eluted with 0.1 M glycine/HCl, pH 2.0,
and 1 M Tris (unbuffered) was added to the eluted proteins to raise
the pH to 7.5. Eluted proteins were analysed by SDS-PAGE and
Western blotting.
Contact factor and fibrinogen binding studies. An overnight
culture of bacteria grown to stationary phase was washed twice and
resuspended in PBS. One hundred microlitres of a 2610
9 bacteria
ml
21 suspension was incubated with 100 ml PBS, 80 mgH Km l
21 and
FXI/FXII/PK, respectively, for 1 h at 37 uC. The contact factors were
used at human plasma concentrations (5 mg FXI ml
21,3 0mg FXII
ml
21 and 40 mgP Km l
21). As a control, bacteria were also incubated
with PBS only. For the fibrinogen binding studies, 100 mlo fa2 610
9
bacteria ml
21 suspension was incubated with 100 ml PBS and 300 mg
fibrinogen ml
21 for 1 h at 37 uC. The bacterial cells were recovered
and washed with PBS four times to remove any unbound plasma
proteins. Bound proteins (proteins bound to the surface of the
bacteria and not removed by washing) were eluted with 0.1 M
glycine/HCl, pH 2.0, and 1 M Tris (unbuffered) was added to the
eluted proteins to raise the pH to 7.5. Eluted proteins were
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followed by centrifugation at 15000 g (4 uC for 20 min). Precipitated
material was dissolved in SDS sample buffer and analysed by SDS-
PAGE and Western blotting.
Enzyme digestions and affinity chromatography. Bacteria were
cultivated overnight to stationary phase and digestions of bacteria
with papain, pepsin and trypsin were performed as described by
Bjo ¨rck (1988). For mutanolysin digestion, the bacteria were washed
and resuspended in 0.01 M KH2PO4, pH 6.8, to 2610
10 bacteria
ml
21. To 1 ml bacterial suspension, 10 U mutanolysin (Sigma) and
2 mg DNase were added, and the mixture was incubated at 37 uC for
2 h. To terminate the reaction, pH was adjusted to 7.5 with 7.5% (w/
v) NaHCO3. Bacteria were pelleted by centrifugation at 4000 g at 4 uC
for 15 min and the remaining supernatant was subjected to affinity
chromatography by using fibrinogen coupled to cyanogen bromide
(CNBr)-activated Sepharose 4B (GE-Healthcare) as described by the
manufacturer. Following extensive washing with PBS, bound proteins
were eluted with 0.1 M glycine/HCl, pH 2.0, and the pH was raised to
approximately 7.4 with 1 M Tris (unbuffered). Fractions were
subjected to SDS-PAGE and Western blot analysis. As a control, the
mutanolysin-released surface proteins were also subjected to a non-
conjugated CNBr-activated Sepharose 4B column to ensure no non-
specific interactions were taking place with the resin.
SDS-PAGE and Western blot analysis. SDS-PAGE was performed
as described by Neville (1971). Samples were prepared for loading by
boiling in sample buffer containing 2% SDS and 5% b-mercap-
toethanol for 5 min, and 12 and 15% gels were used to resolve plasma
proteins eluted from the bacterial surface. Separated proteins were
visualized by Coomassie blue staining. For Western blot analysis,
proteins were electrophoretically transferred to a PVDF membrane
(Amersham Biosciences). Subsequently, the membrane was blocked
in a PBS-Tween [PBS containing 0.1% Tween 20 (PBS-T)] solution
containing 5% (w/v) skimmed milk powder at 37 uC for 30 min.
Membranes were washed three times with PBS-T for 5 min followed
by incubation with primary antibodies (rabbit anti-NAT26, 1:100
dilution; rabbit anti-human fibrinogen, 1:1000 dilution; sheep anti-
human FXII, 1:1000 dilution; goat anti-human FXI, 1:1000 dilution;
rabbit anti-human PK, 1:1000 dilution) in blocking buffer at 37 uC
for 30 min. Membranes were washed three times with PBS-T for
5 min followed by incubation with HRP-conjugated secondary
antibodies (protein A, 1:5000 dilution; goat anti-rabbit IgG,
1:5000 dilution; or donkey anti-sheep IgG, 1:5000 dilution) in
blocking buffer at 37 uC for 30 min. Following a repeat of the wash
steps, bound antibodies were detected by chemiluminesence as
described by Nesbitt & Horton (1992).
Clotting assays. An overnight culture of bacteria grown to
stationary phase was washed with 13 mM sodium citrate solution
and made to a concentration of 2610
10 bacteria ml
21 by using the
same buffer. One hundred microlitres of human plasma was
incubated with 30 ml of the bacterial suspension for 1 h at 37 uC.
The bacteria were recovered by centrifugation at 13000 g at room
temperature for 1 min and the supernatant was used in the clotting
assays. For the intrinsic pathway of coagulation [activated partial
thromboplastin time (aPTT) assay], 100 ml DAPTTIN (double
activated aPTT) (Technoclone) was incubated with 100 mlo f
supernatant for 200 s at 37 uC in a coagulometer (Amelung). Then,
100 ml of 25 mM CaCl2 was added and the time taken to form a clot
was measured. For the extrinsic pathway of coagulation [prothrombin
(PT) time assay], 100 ml TriniCLOT PT Excel (Kordia) was added to
100 ml supernatant in a coagulometer at 37 uC, and the time taken to
form a clot was measured. For the common pathway of coagulation
[thrombin (TCT) time], 100 ml thrombin (Hyphen Biomed) was
added to 100 ml supernatant in a coagulometer at 37 uC, and the time
taken to form a clot was measured.
Assay for FXIIa, FXIa and activated PK. An overnight culture of
bacteria grown to stationary phase was washed with 13 mM sodium
citrate and made to a concentration of 2610
10 cells ml
21 by using the
same buffer. One hundred microlitres of human plasma was incubated
with 30 ml of the bacterial suspension for 30 min at 37 uC. Plasmas
deficient in FXII, FXI and PK were used as controls. Bacteria were
recovered by centrifugation at 13000 g at room temperature for 1 min
and the supernatant was discarded. The cell pellet was washed once
with 200 ml 13 mM sodium citrate solution to remove unbound
plasma proteins and subsequently resuspended in 100 ml of S-2302
chromogenic substrate (Chromogenix). The mixture was incubated at
room temperature for 30 min. The bacterial cells were recovered as
before and 100 ml of the supernatant was transferred to an ELISA plate.
The absorbance of the substrate was measured at 405 nm. S-2302 is a
fluorescent substrate for FXIIa, FXIa and activated PK in plasma. An
increase in absorbance is indicative of deposition of activated plasma
components at the cell. Following resuspension of bacterial cells in the
chromogenic substrate, a time-dependent recordingofprotease activity
was also performed directly in the bacterial suspensions.
Detection of bradykinin by ELISA. Bacterial samples for ELISA
were prepared by preincubating 100 mlo fa2 610
10 bacteria ml
21
suspension, from a culture grown overnight to stationary phase, with
100 ml human plasma at room temperature for 15 min. Following
incubation, the bacteria were recovered as above and the supernatant
was discarded. Pellets were resuspended in 50 mM Tris-HCl, pH 7.5,
containing 50 mM ZnCl2 and allowed to stand at room temperature for
15 min. Following incubation, the cells were recovered by centrifu-
gation as described above, and the supernatant was transferred to a
fresh tube and 10 ml TCA solution (provided with the ELISA kit) was
added. The resulting precipitate was removed by centrifugation at
14000 g for 2.5 min at room temperature. Thesupernatant(50 ml) was
transferred to a fresh tube containing 50 ml Buffer B (from Markit-M
Bradykinin kit). Samples were stored at 220 uC for further analysis.
The bradykinin ELISA was carried out by using the Markit-
M Bradykinin kit according to the manufacturer’s instructions.
Absorbance was measured at 405 nm, and the concentration of
bradykinin in the samples was calculated by using a standard curve.
MS and N-terminal amino acid sequencing. Protein bands on
SDS-PAGE were excised and subjected to in-gel trypsination and MS/
MS analysis. This was performed at the SCIBLU-Swegene Centre for
Integrative Biology at Lund University, Sweden. The residues of the
individual peptide sequence interpretations were used for a search of
the B. fragilis 638R sequence by using Artemis sequence visualization
software (Rutherford et al., 2000). N-terminal amino acid sequencing
was performed on an ABI Procise 494 sequencer at Alphalyse.
Thin-sectioning and transmission electron microscopy. An
overnight culture of bacteria grown to stationary phase was washed
with 13 mM sodium citrate and adjusted to 2610
10 bacteria ml
21 by
usingthesamebuffer.Thirty microlitresofthebacterialsuspension was
incubated with 100 ml citrated human plasma or buffer for 1 h at
37 uC. Following incubation, the bacteria were recovered by centrifu-
gation at 3000 g and fixed for 1 h at room temperature and then
overnight at 4 uC in 2.5% (v/v) glutaraldehyde in 0.15 M sodium
cacodylate, pH 7.4 (cacodylate buffer). Samples were washed with
cacodylate buffer, dehydrated in a graded series of ethanol solutions
and then embedded in Epon 812 by using acetone as an intermediate
solvent. Specimens were sectioned with a diamond knife into 50-nm-
thick ultrathin sections on an LKB ultramicrotome and mounted on
gold grids. For immunostaining, grids were floated on top of drops of
immune reagents displayed on a sheet of Parafilm. Free aldehyde
groups were blocked with 50 mM glycine in PBS, followed by
incubation with 5% (v/v) goat serum in incubation buffer [0.2%
BSA-c in PBS (acetylated bovine serum albumin from Aurion), pH 7.6]
for 15 min. This blocking procedure was followed by overnight
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incubation buffer), rabbit anti-NAT26 (diluted 1:10 in incubation
buffer) or sheep anti-human HK AS88 (diluted 1:10 in incubation
buffer), respectively. After washing the grids in a large volume (200 ml)
of incubation buffer, floating on drops containing gold-conjugated
reagent (goat anti-rabbit IgG coupled to 10-nm gold particles at
1 mgm l
21 in incubation buffer, or donkey anti-sheep IgG coupled to
5-nm gold particles at 1 mgm l
21 in incubation buffer) was performed
for 2 h at 4 uC. After further washes in a large volume of incubation
buffer, the sections were post-fixed in 2% glutaraldehyde. Finally,
sections were washed with distilled water, post-stained with 2% uranyl
acetate and lead citrate, and examined with a JEOL JEM 1230 electron
microscope operated at 80 kV accelerating voltage. Images were
recorded with a Gatan Multiscan 791 charge-coupled device camera.
RESULTS
HK binds to the surface of B. fragilis and B.
thetaiotaomicron
To investigate if Bacteroides can take up HK, the precursor
of bradykinin, from plasma, B. fragilis and B. thetaiotao-
micron were incubated with human plasma for 1 h at
37 uC. Bacteria incubated with PBS were used as a control.
Following incubation, the bacterial cells were washed, and
bound proteins were eluted with a low-pH buffer and
analysed by SDS-PAGE (Fig. 1a). B. fragilis appears to bind
a broader range of plasma proteins than B. thetaiotaomi-
cron. Furthermore, by comparison with the control it can
be seen that most of the proteins in the B. thetaiotaomicron
sample appear to be of bacterial origin, presumably outer-
membrane proteins released under the low-pH conditions
(Fig. 1a). Western blot analysis with an anti-NAT26
antibody, which reacts with the D3 domain of the heavy
chain of HK, demonstrated that this protein was bound to
the surface of B. fragilis (Fig. 1b, lane 3). When the contact
system is activated, PK cleaves native HK (120 kDa) into a
heavy chain of ~65 kDa and a light chain of ~55 kDa. HK
eluted from B. fragilis was cleaved into a smaller fragment
(the size of the immunoreactive band was only ~55 kDa,
Fig. 1b). This fragment is most likely generated by further
processing of the HK heavy chain.
Next, B. fragilis and B. thetaiotaomicron were incubated
with purified intact HK at a concentration corresponding
Fig. 1. Bacteroides bind HK. (a) B. fragilis and B. thetaiotaomicron were incubated with human plasma or PBS for 1 h at 37 6C.
Bacteria were washed, and bound plasma proteins were eluted at low pH and subjected to SDS-PAGE. The gel was stained with
Coomassie blue. Lanes: 1, B. fragilis+PBS; 2, B. fragilis+plasma; 3, B. thetaiotaomicron+PBS; 4, B. thetaiotaomicron+plasma.
(b) Western blot analysis ofthe samplesin(a) usingantibodiesagainst the NAT26 peptide derived fromdomain D3ofHKasprobe.
Lanes: 1, native HK; 2, B. fragilis+PBS; 3, B. fragilis+plasma; 4, B. thetaiotaomicron+PBS; 5, B. thetaiotaomicron+plasma;
6, prestained protein marker. The arrow points to the HK fragment bound by B. fragilis. (c) Binding of HK to the surface of B. fragilis
(i) and B. thetaiotaomicron (ii). Lanes: 1, native HK; 2, B. fragilis/B. thetaiotaomicron+HK; 3, B. fragilis/B. thetaiotaomicron+PBS;
4, prestained protein marker. (d) Proteins were released from the surface of B. fragilis by mutanolysin treatment, precipitated with
TCA and subjected to SDS-PAGE. Separated proteins were transferred to a PVDF membrane, which was incubated with HK
(20 mgm l
”1)followedbyanti-NAT26antibodies.FourproteinfragmentsinteractingwithHKwereidentified(indicatedbynumbers).
Lanes: 1, SDS profile of mutanolysin extract; 2, native HK; 3, surface proteins of B. fragilis binding to HK; 4, prestained protein
marker.
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21) for 1 h at 37 uC.
Bacteria were also incubated with PBS only as a negative
control. In contrast to the plasma absorption experiment,
both Bacteroides species bound purified HK, as demon-
strated by Western blot analysis using antibodies against
NAT26 (Fig. 1c). Furthermore, bound HK was degraded
(Fig. 1c), suggesting that, in the absence of activated PK,
HK is probably cleaved by a protease expressed by the
bacteria. Such activity has been described for proteases
from various bacterial species (Frick et al., 2007; Imamura
et al., 2004).
To release the HK binding protein from the bacterial cell
surface, B. fragilis was treated with pepsin, papain, trypsin or
mutanolysin as described by Bjo ¨rck (1988). The proteins
released from B. fragilis were analysed by SDS-PAGE and
Western blotting, and although mutanolysin has mainly
been used for digestion of Gram-positive bacterial cell walls
(Yokogawa et al., 1974), this enzyme was the most efficient
in releasing membrane proteins of B. fragilis. The material
extracted with mutanolysin (Fig. 1d, lane 1) contained four
protein fragments, which reacted with HK (Fig. 1d, lane 3).
This was demonstrated through incubation of the blot with
HK followed by detection of HK binding through the anti-
NAT26 antibody. These four proteins were subjected to MS/
MS analysis (Fig. 1d). Protein nos 1 and 4 were identified as
a chaperone GroEL and a malate dehydrogenase, respect-
ively. Protein no. 3 was identified as a 41 kDa hypothetical
protein and protein no. 2 as a 60.5 kDa hypothetical protein
with a SusD/RagB domain. A BLAST analysis of protein 2
showed that it had high homology to putative outer-
membrane proteins and proteins involved in nutrient
binding with a SusD/RagB domain. Due to its size, location
and strongest reactivity in the Western blot, protein 2
(BF638R1721) is suggested to be a putative HK binding
protein at the surface of B. fragilis.
B. fragilis and B. thetaiotaomicron bind and
activate contact factors on their surface
To examine further the interaction of contact factors with
the bacterial surface of Bacteroides, B. fragilis and B.
thetaiotaomicron were incubated with HK together with
either FXI, FXII or PK in a PBS solution for 1 h at 37 uC.
All contact factors were used at concentrations corre-
sponding to those in human plasma. As a control, the
bacteria were incubated with PBS only. Proteins bound to
the bacteria were eluted at low pH, followed by Western
blot analysis and detection of bound protein with
antibodies. Co-incubation with FXI showed that both
bacteria were capable of binding and activating FXI on
their surface (Fig. 2a). There are no bands in the PBS
control fraction; therefore, the bands in lanes 2 and 4 are
associated with FXI binding. Activation of FXI proceeds
through cleavage of the Arg369–Ile370 peptide bonds on
both subunits of the dimer. This proceeds through an
intermediate with one activated subunit, referred to as K-
FXIa (Emsley et al., 2010). The presence of three bands on
the blot suggests the existence of inactive, intermediate and
fully activated FXI on the bacterial surface, as different
protein conformations migrate at slightly different rates
(Emsley et al., 2010). Co-incubation of both bacterial
species with FXII produced a similar outcome (Fig. 2b).
The two immunoreactive bands of approximately 52 and
28 kDa correspond to the heavy chain (HCFXII) and light
chain (LCFXII) components of FXII upon cleavage (Harris
et al., 2005). A very faint band is observed at 80 kDa, the
molecular mass of intact FXII. Therefore, the majority of
FXII has been activated on the bacterial surface.
Investigation of the binding of PK to the surface of B.
fragilis and B. thetaiotaomicron revealed an immunoreac-
tive fragment of approximately 55 kDa, suggesting binding
and activation of PK by both bacteria (Fig. 2c).
Fig. 2. B. fragilis and B. thetaiotaomicron activate the contact system. (a) Binding of FXI to the surface of Bacteroides. Lanes: 1,
native FXI; 2, B. thetaiotaomicron+FXI; 3, B. thetaiotaomicron+PBS; 4, B. fragilis+FXI; 5, B. fragilis+PBS; 6, prestained
protein marker. The arrowheads point to activated conformations of FXI. (b) Binding of FXII to the surface of Bacteroides. Lanes:
1, native FXII; 2, B. thetaiotaomicron+FXII; 3, B. thetaiotaomicron+PBS; 4, B. fragilis+FXII; 5, B. fragilis+PBS; 6, prestained
protein marker. The arrowheads point to intact FXII, HCFXII and LCFXII, respectively. (c) Binding of PK to the surface of
Bacteroides. Lanes: 1, native PK; 2, B. thetaiotaomicron+PK; 3, B. thetaiotaomicron+PBS; 4, B. fragilis+PK; 5, B.
fragilis+PBS; 6, prestained protein marker.
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the presence of active PK, FXIIa and FXIa by monitoring
fluorescence as a result of hydrolysis of S-2302. Therefore,
the interaction of the contact factors with the surface of
Bacteroides was further investigated by incubating the
bacteria with human plasma and then testing for the
presence of PK, FXIIa and FXIa by hydrolysis of S-2302.
For B. fragilis and B. thetaiotaomicron cells incubated in
normal plasma, there was an increased fluorescence
compared with controls, indicating that the contact system
had been activated (Fig. 3a). In additional experiments,
bacteria were incubated with plasma deficient in either PK,
FXI or FXII and with 13 mM sodium citrate solution
(negative control). The negative control gave a mean
absorbance that was only 11% of maximal activation. This
was comparable with that of plasma deficient in FXII. The
plasma deficient in PK gave an absorbance that amounted
to 16% of maximal activation, probably as a result of
activated FXI and FXII present in the kallikrein-depleted
plasma. Finally, the plasma deficient in FXI gave an
absorbance corresponding to 36% of the maximal
activation caused by bacteria incubated in normal plasma.
This activity can be accounted for by the presence of
activated FXII and kallikrein in the plasma. In the presence
of H-D-Pro-Phe-Arg-CMK, an inhibitor of FXII and PK
activation, contact activation was efficiently blocked by
both bacteria in normal plasma (Fig. 3a). In addition, time-
dependent recording of the protease activity clearly
demonstrated the presence of active contact factors on
the bacterial surface (Fig. 3b).
Overall, these results strongly suggest that B. fragilis and B.
thetaiotaomicron are capable of activating the human
contact system through recruitment and activation of
contact factors on the bacterial surface.
B. fragilis interacts with fibrinogen via an outer-
membrane protein
It was recently shown that B. fragilis binds and degrades
purified human fibrinogen, a major clotting protein of
plasma (Houston et al., 2010). Thus, the plasma proteins
bound by both B. fragilis and B. thetaiotamicron (Fig. 1a)
were also analysed for fibrinogen binding by Western
blotting by using an anti-fibrinogen antibody as a probe.
However, a very low level of reaction was obtained (data
not shown). Therefore, B. fragilis and B. thetaiotaomicron
were incubated with human fibrinogen followed by
Western blot analysis with antibodies against fibrinogen.
This blot showed a definite interaction between both B.
fragilis and B. thetaiotaomicron with fibrinogen (Fig. 4a).
The outer-membrane proteins released from B. fragilis by
mutanolysin were then tested in a Western blot for a
possible interaction with fibrinogen. Following incubation
with human fibrinogen, bound protein was detected with
an anti-fibrinogen antibody. However, due to weak
binding, this blot did not give a clear indication of which
outer-membrane proteins from B. fragilis were capable of
binding fibrinogen (data not shown). Therefore, the
proteins released by mutanolysin were applied to affinity
chromatography by using fibrinogen-coupled Sepharose. A
protein of approximately 18 kDa was eluted from the
Fig. 3. Determination of contact system activation by Bacteroides
by using a chromogenic substrate. (a) Examination of contact
system activation by B. fragilis and B. thetaiotaomicron in normal
plasma and plasma deficient in PK, FXI or FXII, and a negative
control (13 mM sodium citrate buffer) by using the S-2302
chromogenic substrate. The bacteria were also incubated with an
inhibitor of FXII and PK activation, CMK. Experiments were
repeated three times, and a representative experiment is shown.
(b) Examination of contact system activation by Bacteroides, at the
indicated bacterial concentrations, by using the S-2302 chromo-
genic substrate in a time-dependent manner: (i) B. fragilis and (ii)
B. thetaiotaomicron. The experiment was performed once.
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http://mic.sgmjournals.org 2099fibrinogen–Sepharose (Fig. 4b, lanes 6 and 7) and subjected
to N-terminal amino acid sequencing. The same procedure
was carried out on a non-conjugated CNBr-activated
Sepharose column and no proteins were purified (data
not shown), signifying a specific interaction of the cell
surface protein with fibrinogen. Furthermore, the affinity
purified fractions were subjected to Western blot analysis
to confirm fibrinogen interaction. The blot was incubated
with a fibrinogen solution and bound protein was detected
with anti-fibrinogen antibodies (Fig. 4c). The immuno-
reactive band at approximately 18 kDa shows that the
purified protein does, in fact, bind fibrinogen. A search of
the B. fragilis 638R genome with the obtained N-terminal
sequence (LMGEA) identified it as being internal to a
hypothetical protein of 57.7 kDa (BF638R0397). The size
of the protein fragment starting at LMGEA is 21 kDa.
Although this fragment is larger than the detected 18 kDa
protein, it is possible that both N- and C-terminal
processing of the 57.7 kDa precursor has occurred. One
other hit for the amino acid sequence LMGEA was
identified in the translated protein repertoire from B.
fragilis 638R. This sequence was within a protein
(BF638R1117) and very close to the C terminus and would
result in a 12.6 kDa protein, which is too small to be the
protein eluted from the fibrinogen-coupled Sepharose
column. A BLAST (Altschul et al., 1990) analysis of the
amino acid sequence of the 57.7 kDa protein showed that
it contained a SusD/RagB domain and that it had high
homology to outer-membrane proteins and proteins with a
SusD/RagB domain. There was 18% identity and 29%
similarity to the recently published fibrinogen-binding
protein in B. fragilis, BF-FBP (Houston et al., 2010),
suggesting that Bacteroides absorbs fibrinogen to its surface
via several proteins. This result suggests that B. fragilis has
two surface proteins capable of binding human fibrinogen.
Alignment of this protein to the potential HK binding
protein identified above was carried out by using the ‘BLAST
2 sequences’ program (Altschul et al., 1990). This analysis
revealed that the proteins are 25% identical and 40%
similar. Therefore, there is a significant level of similarity
between these two proteins.
B. fragilis and B. thetaiotaomicron cause
prolongation of the intrinsic pathway of clotting in
human blood
Due to the ability of Bacteroides to bind fibrinogen and to
investigate further the bacterial interaction with the contact
system, the effect of the bacteria on different pathways of
coagulation was examined. All three pathways of clotting
were tested (assays used to test them in parentheses): the
intrinsic pathway (aPTT), the extrinsic pathway (PT) and
the common pathway (TCT). The extrinsic pathway of
coagulation is initiated in response to trauma, where tissue
factor becomes exposed and binds to the activated form of
factor VII (Dahlba ¨ck, 2000). The intrinsic pathway of
coagulation is initiated by activation of the contact system,
where FXII activates FXI in its complex with HK. Initiation
of this pathway is not associated with trauma-initiated
coagulation and the mode of activation on cellular surfaces
has not yet been fully elucidated (Dahlba ¨ck, 2000;
Oehmcke & Herwald, 2010). However, once activated,
the contact system is involved in regulation of haemostatic
and inflammatory processes (Oehmcke & Herwald, 2010).
Fig. 4. Bacteroides bind fibrinogen. (a) B.
fragilis and B. thetaiotaomicron were incu-
bated with fibrinogen (300 mgm l
”1) or PBS.
Bound protein was eluted, analysed by
Western blotting and probed with anti-fibrino-
gen antibodies. Lanes: 1, prestained protein
marker; 2, B. fragilis+PBS; 3, B. fragilis+
fibrinogen; 4, B. thetaiotaomicron+PBS; 5, B.
thetaiotaomicron+fibrinogen; 6, human fibrino-
gen. (b) Coomassie blue-stained gel showing
enrichment of an 18 kDa protein that binds to
fibrinogen coupled to Sepharose. Lanes: 1,
prestained protein marker; 2, proteins released
from the surface of B. fragilis by mutanolysin; 3,
run-through from the column; 4–8, protein
eluted in fractions from the column. The band
indicated with an arrow was subjected to N-
terminal amino acid sequencing. (c) Purified
proteins from (b) were transferred to a PVDF
membrane, incubated with a 20 mg fibrinogen
ml
”1solutionandprobedwithananti-fibrinogen
antibody. Lanes: 1, prestained protein marker;
2–4, protein eluted in fractions from the
fibrinogen–Sepharose column.
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in the clotting times for all three pathways. The TriniCLOT
reagent used in the PT assay is sensitive to deficiencies in
factors VII and X. This prolongation of the extrinsic
pathway of coagulation times suggests that Bacteroides may
be binding these clotting factors to their surface, leading to
a depletion in plasma (Fig. 5a). The TCT for the common
pathway of coagulation was also significantly delayed (Fig.
5b). This result suggests a depletion of fibrinogen in
plasma, which agrees with the finding that both B. fragilis
and B. thetaiotaomicron interact with fibrinogen and also
with the recent identification of a fibrinogen-binding
p r o t e i no nt h es u r f a c eo fB. fragilis (Houston et al.,
2010). In addition, both bacterial species had a
significant effect on the intrinsic pathway (Fig. 5c),
causing a prolongation of clotting times in the aPTT
a s s a yc o m p a r e dw i t ht h en e g a t i v ec o n t r o l( 1 3 m M
sodium acetate buffer), with B. fragilis (228 s mean
clotting time) being slightly more effective than B.
thetaiotaomicron (212 s mean clotting time). As LPS of
Gram-negative bacteria has been shown to activate the
contact system (Kalter et al., 1983), the aPTT assay was
also conducted by adding polymyxin B to neutralize the
effect of LPS (Cardoso et al., 2007). In the presence of
polymyxin B at neutralizing concentrations, both
Bacteroides species still significantly delayed the clotting
time (data not shown), demonstrating that other
components on the bacterial surface are responsible for
binding and assembly of the contact factors.
A further clotting experiment was carried out by using the
aPTT assay to investigate clotting times of bacteria pre-
incubated in normal plasma for 1 h at 37 uC, harvested and
resuspended in FXI-deficient plasma. The control, which
consisted of FXI-deficient plasma and sodium citrate
buffer, had a mean clotting time of 151 s. This clotting
time is significantly longer than in normal plasma (45 s)
due to the absence of FXI, which is necessary to initiate the
intrinsic pathway of coagulation (Fig. 5d). However,
bacterial pellets that were resuspended in FXI-deficient
plasma had a mean clotting time of 56 s for B. fragilis and
54 s for B. thetaiotaomicron in the aPTT assay (Fig. 5d).
This result signifies binding and activation of FXI on the
surface of both bacteria during incubation in normal
plasma. Upon resuspension in FXI-deficient plasma, the
FXIa bound to the surface of the bacteria initiates the
intrinsic pathway of coagulation, and clotting times are
almost that of the normal plasma control (45 s).
Prolongation of clot formation is a sign of a deficiency of
coagulation factors such as contact-phase proteins and
fibrinogen (Ponjee et al., 1991). Therefore, it would appear
that both bacteria are capable of activating the contact
system.
B. fragilis and B. thetaiotaomicron induce release
of bradykinin from HK in human plasma
As a consequence of contact activation, bradykinin is
released from HK through cleavage by PK. Bradykinin is a
Fig. 5. Effect of Bacteroides on the intrinsic, extrinsic and common pathways of coagulation. (a–c) B. fragilis (BF) and B.
thetaiotaomicron (BT) were incubated with human citrated plasma for 1 h at 37 6C. Bacteria were removed and the resulting
plasma supernatants were analysed by clot formation tests. For the negative control, bacteria were substituted with 13 mM
sodium citrate solution. Data are means±SD from three experiments. (a) PT clot formation test, (b) TCT clot formation test and
(c) aPTT clot formation test. (d) B. fragilis and B. thetaiotaomicron were incubated with human citrated plasma for 1 h at 37 6C.
Bacteria were harvested and the resulting plasma supernatants were analysed by the aPTT clot formation test. The resulting
bacterial pellets were resuspended in 100 ml FXI-deficient plasma, and clot formation was also analysed. For the negative
control, bacteria were substituted with 13 mM sodium citrate buffer. Data are means±SD from three experiments.
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many inflammatory responses. These include increased
microvascular permeability, smooth-muscle contraction,
fever and pain (Bhoola et al., 1992; Hall, 1992). B. fragilis
and B. thetaiotaomicron were incubated in human plasma
and bradykinin release was measured by using the
MARKIT-M bradykinin ELISA kit. Kaolin was used as a
positive control as it has a negatively charged surface and
causes massive activation of the contact system. In this
system, kaolin activation resulted in release of 2830 pg
bradykinin ml
21, while the negative control, 50 mM Tris-
HCl, pH 7.5, containing 50 mM ZnCl2, released
103 pg ml
21 (Fig. 6). Although values were lower than
the positive control, both bacterial species caused a
significant release of bradykinin. B. thetaiotaomicron caused
a release of 895 pg ml
21 and appears to be slightly more
effective than B. fragilis, which caused a release of 781 pg
bradykinin ml
21 (Fig. 6). In the presence of the FXII and
PK inhibitor H-D-Pro-Phe-Arg-CMK, bradykinin release
by the bacteria was completely inhibited (data not shown).
Hence, it would appear that bradykinin release is occurring
on the surface of the bacteria as a result of contact
activation.
Further processing of HK at the surface of bacterial
pathogens has been shown to generate antibacterial
fragments of HK, mainly involving the peptide sequence
NAT26 (Frick et al., 2006). However, no such fragments
were observed when either of the Bacteroides species in this
study was incubated in human plasma (Fig. 1b).
Analysis of fibrinogen and HK binding to the
surface of B. fragilis and B. thetaiotaomicron by
electron microscopy
Binding of HK and fibrinogen to the bacteria was
examined visually by using immunoelectron microscopy.
Samples were prepared by preincubating bacteria with
human plasma for 1 h at 37 uC followed by thin sectioning
of the bacteria. The apparent shrinkage of the cytoplasm
seen in Fig. 7(a, e) is a result of morphological changes to
the cells during chemical fixation. Chemical fixation causes
the cells to lose matter and swell slightly, and as a result, the
corresponding electron micrographs show gap formation
by curdling and a decreased concentration of the cytoplasm
(Kellenberger et al., 1992). Binding of specific plasma
proteins was determined by initially incubating the thin
sections of bacteria with a primary antibody. These
antibodies included anti-human fibrinogen, anti-kininogen
AS88 (which probes for intact HK) and anti-NAT26
(which probes for a peptide sequence in domain D3 of
HK). Binding of these antibodies was detected by
incubation with a gold-labelled secondary antibody which
could be visualized by electron microscopy (Fig. 7).
Following exposure to plasma, cell morphology of B.
fragilis and B. thetaiotaomicron was unaffected, as evi-
denced by an electron-dense cytoplasm (Fig. 7a, e).
Immunostaining revealed that fibrinogen and HK are
bound by both bacteria and, as judged from the images, the
binding of these plasma proteins is surface-associated (Fig.
7b–d, f–h). Overall, these findings support the results
demonstrating that both bacterial species caused activation
of the contact system and that the mechanism involves HK
binding. Also, both bacteria caused prolongation of the
intrinsic pathway of coagulation, which could be a result of
fibrinogen-binding and contact system activation. Hence,
these images provide strong visual support for both HK
and fibrinogen binding to the Bacteroides species tested.
DISCUSSION
During the establishment of an infection, bacteria must
first overcome many of the host’s immune responses. One
such response is activation of the contact system, which
results in initiation of many procoagulative and proin-
flammatory cascades such as release of the proinflamma-
tory peptide bradykinin and initiation of the intrinsic
pathway of coagulation (Risberg et al., 1991). Activation of
the contact system also generates antibacterial peptides
from domain D3 of HK (Frick et al., 2006). However, over-
activation of the contact system can have a deleterious
effect on the host and be an important pathogenicity factor
for invading pathogens. Large increases in vascular
permeability enable invading pathogens to access more
nutrients and colonize other tissue sites of the human host.
Therefore, the ability of a pathogen to activate the contact
system and thereby modulate the host immune response
can increase virulence and confer advantages on the
bacterium during infection.
In the present investigation, two species of the obligately
anaerobic genus Bacteroides, B. fragilis and B. thetaiotao-
micron, were found to interact with components of the
contact system. Although normally a commensal organism,
Bacteroides can cause significant opportunistic infections,
including abscess formation and bacteraemia, with B.
fragilis being regarded as the most virulent species (Wexler,
2007). Rapid binding and activation of the contact factors
Fig. 6. Bradykinin is released by B. fragilis (BF) and B.
thetaiotaomicron (BT). Bacteria were incubated with human
plasma (final concentration 50%) as described in Methods.
Kaolin was used as a positive control and buffer was used as a
negative control. Released bradykinin was determined by ELISA.
Data are means±SD from three experiments.
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release of bradykinin. In addition, activation of FXI at the
bacterial surface initiated the intrinsic pathway of coag-
ulation. When released during contact activation, brady-
kinin plays an important role in inflammation, and several
studies suggest that an uncontrolled activation of the
contact system contributes to the symptoms seen in sepsis
(Bhoola et al., 1992; Joseph & Kaplan, 2005). Several studies
have reported efficient activation of contact factors by
important pathogenic bacteria and/or their products. For
instance, Escherichia coli and Salmonella species expressing
curli fibres and M proteins of Streptococcus pyogenes are able
to assemble contact factors on their surface, leading to
bradykinin release (Ben Nasr et al., 1995, 1996; Herwald
et al., 1998; Persson et al., 2000). Staphylococcus aureus,a
frequent causativeagent of sepsis, canrelease bradykinin asa
result of contact activation on the bacterial surface
(Mattsson et al., 2001) and also through secretion of
cysteine proteinases that can cleave HK (Imamura et al.,
2005). Both B. fragilis and B. thetaiotaomicron caused
significant levels of bradykinin to be released in human
plasma, a mechanism that will provide the bacteria with an
opportunity to spread during infection.
Fibrinogen is a major clotting protein of plasma, and
recently a putative surface lipoprotein, BF-FBP, was
identified as a fibrinogen binding protein in B. fragilis
(Houston et al., 2010). This protein displays very low
homology (18% identity) with the outer membrane
57.7 kDa hypothetical protein identified in this study as a
putative fibrinogen binding protein, indicating that
Bacteroides have evolved different proteins for adsorption
of this key molecule of blood coagulation. Depletion of
fibrinogen and contact factors in human plasma causes a
hypocoagulative state (Ponjee et al., 1991), and the
significant delay in intrinsic, extrinsic and common
pathway clotting times caused by both Bacteroides species
tested in this study (see Fig. 5a–c) emphasizes that the
bacteria adsorb these factors to its surface. In the case of
Salmonella, an equivalent number of bacterial cells as used
for Bacteroides caused a ~75 s delay in intrinsic clotting
times and contact activation on its surface generated active
thrombin (Persson et al., 2000), which suggests that both B.
fragilis and B. thetaiotaomicron are efficient inducers of
contact activation. The observed prolongation of the tissue
factor-driven coagulation further emphasizes that fibrino-
gen depletion by these Bacteroides species will prevent clot
formation. In relation to the study carried out by Houston
et al. (2010), it is interesting that a fibrinolytic activity was
detected in B. fragilis culture supernatants. This is in
contrast with the present investigation where no such
activity was found (data not shown). However, different
incubation times and enzyme concentrations may explain
this discrepancy. Indeed, the observed prolonged thrombin-
induced coagulation time following plasma exposure to
Bacteroides might reflect not only depletion of fibrinogen
but also proteolytic cleavage leading to inhibition of fibrin
network formation.
The capsule in B. fragilis is regarded as playing a role in
virulence and in abscess formation (Tzianabos et al., 1993),
and being involved in protection against phagocytic uptake
and killing (Reid & Patrick, 1984). Interestingly, B. fragilis
expresses multiple capsular polysaccharides and the
Fig. 7. Transmission electron micrographs of B. fragilis and B. thetaiotaomicron incubated in human plasma. Following
incubation, the bacteria were prepared for ultrathin sectioning/immunoelectron microscopy. Sections were incubated with
primary antibodies to human fibrinogen, HK AS88 or NAT26, followed by secondary antibodies (1 mgm l
”1) labelled with
colloidal gold. (a) B. fragilis incubated in plasma for 1 h, (b) B. fragilis probed with rabbit anti-human fibrinogen antibody, (c) B.
fragilis probed with anti-HK AS88, (d) B. fragilis probed with anti-NAT26, (e) B. thetaiotaomicron incubated in plasma for 1 h,
(f) B. thetaiotaomicron probed with rabbit anti-human fibrinogen antibody, (g) B. thetaiotaomicron probed with anti-HK AS88;
and (h) B. thetaiotaomicron probed with anti-NAT26. The inset images represent the negative control which was Bacteroides
incubated with sodium citrate buffer only instead of human plasma. Bars, 1 mm for (a) and (e), 100 nm for (b)–(d) and (f)–(h).
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polysaccharides, a process regulated by phase variation
(Krinos et al., 2001). Furthermore, within an individual
strain of B. fragilis, various encapsulated variants were
observed. Recently, it was also shown that Bacteroides not
commonly associated with opportunistic infection also
contain diverse polysaccharide loci (Patrick et al., 2010).
Thus, the surface variation of capsular polysaccharides
might have an impact on the binding of plasma proteins to
outer-membrane-anchored bacterial proteins. This could
help explain the low level of binding observed in some
experiments.
Despite the high occurrence of Bacteroides in anaerobic
infections and their levels of antibiotic resistance, little is
known about their virulence mechanisms. The modulation
of normal clot formation and bradykinin release described in
this study represents a novel mechanism that may contribute
to the pathogenicity of Bacteroides. Inhibition of clot
formation under infectious conditions would allow the
bacteriagreater opportunitiestoenlargethe areaofinfection.
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